According to VCBeat, Liangyihui has completed the strategic financing of tens of millions yuan, with participation from the exclusive investor Juhe Capital and the exclusive financial consultant Galaxy Capital. Proceeds of this financing will be used to develop the services for oncology doctors and patients, and pharmaceutical enterprises, build an Internet medical platform and strengthen the popularization and education of patients and the public.
Up to now, Liangyihui has completed three rounds of financing including ¥10M Series A financing from Legend Capital in October 2015, ¥10M Series B financing from Redhill Capital in December 2018.
Founded in 2014, Liangyihui is an online medicine and therapeutic information service platform in oncology and the official platform cooperating with the Chinese Society of Clinical Oncology (CSCO). The company has long-term and in-depth cooperation with many well-known hospitals and authoritative institutions at home and abroad.
Liangyihui is committed to solving the information asymmetry in the field of oncology. The company provides professional knowledge and efficient tools for oncologists to improve diagnosis and treatment, and offers services such as the popularization of science, medical guidance, diagnosis and treatment to cancer patients.
Liangyihui has developed an app for oncologists. The users of its products include 150,000 doctors and 200,000 patients. Liangyihui has gathered a large number of doctors from third-grade first-class hospitals and oncology hospitals, providing academic information and helping doctors build public praise and manage patients. The platform has more than 50,000 pieces of professional content, which has formed a knowledge system that can be close to clinical work and help to solve practical problems.
Besides, Liangyihui provides information for patients' education, covering the most types of tumors, including professional video, lectures, and texts, to guide patients with science popularization and consultation.
About Juhe Capital
Founded in March, 2014, with registered capital of RMB 5 million, Juhe Capital provides investment services for companies, including asset management and capital operation, equity investment, industrial investment, equity investment fund management, financial consultant and so on.
Founded in 2015, Galaxy Capital is a leading investment bank in the primary market in China, focusing on private equity financing services for emerging enterprises in the field of science and technology, consumption, logistics, education, healthcare and so on. Galaxy Capital has helped more than dozens of start-up companies raise a total of nearly 10 billion yuan.